Fangda Partners

Healthcare and life science

Partner

MR. JOSH SHIN SPECIALIZES IN CORPORATE AND COMMERCIAL LAW MATTERS, WITH EXTENSIVE EXPERIENCES IN VARIOUS INDUSTRY SECTORS SUCH AS PHARMA, LIFE SCIENCES, PRIVATE EDUCATION AND GENERAL INDUSTRIES SECTORS. Mr. Shin maintains a balanced practice between transactional and regulatory advisory matters. Leading the life sciences practice within the firm’s corporate group, Josh is well-versed in advising clients on a wide range of legal matters.  He is considered as one of the most active and influential Chinese lawyers in various types of transactions in relevant industries sectors, such as licensing and collaboration and M&A deals.  In these transactional works, his "good business sense" and keen understanding of client needs have earned him praise from those he has worked with.  Additionally, Mr. Shin has a proven track record in advising clients on regulatory-related issues covering a variety of cutting-edge legal issues.  Josh’s clientele commended him that “Finding someone who always has sight of the bigger picture while diving into the smallest details to ensure the quality of work product is not easy. Josh has distinguished himself for his professionalism, enthusiasm to the career and sensitivity of industry.”

Chinese, English

Josh has been dedicated to public welfare and the professional growth of young professionals for many years, and is an active contributor and council member of NGLegal, a youth legal development program.

University College London (UCL), Faculty of Law, LL.M Fudan University, School of Law, LL.B

Honors and Awards Recommended as leading lawyer for healthcare by Chambers and Partners – Asia Pacific 2019 through 2021 and by Chambers and Partners – Greater China 2022 through 2024. Recommended as leading individual for “healthcare and life-science” by Legal 500 –Asia Pacific 2020 through 2023. Recommended as distinguished practitioner in Healthcare legal services by Asia Law 2022 and 2023. Pharmaceutical, Medical and Biotech M&A Legal Advisor of the Year 2019, by Merger Market. Awarded jointly by China Health Consulting and CITIC Securities as “Top 5 Practitioners in Healthcare Sector” in 2023